Research Presentation Sessions: Interventional Radiology
Interventional management of malignant liver lesions
Lectures
1
Introduction by the moderator - Thomas K. Helmberger, Munich / DE
02:00
2
Can microwave ablation of HCC modulate systemic inflammation and immunity? An analysis of factors affecting neutrophil-to-lymphocyte ratio and correlation with local tumour progression - Angelo Della Corte, Milan / IT
08:00
3
Prevalence and clinical significance of clinically evident portal hypertension in patients with hepatocellular carcinoma undergoing transarterial chemoembolisation - Lukas Müller, Mainz / DE
08:00
4
Laser-induced thermotherapy (LITT) versus microwave ablation (MWA) in hepatocellular carcinoma (HCC): therapy response and survival rates - Thomas J. Vogl, Frankfurt a. Main / DE
08:00
5
Treatment of primary and secondary liver tumours using microwave ablation (MWA): MR elastography as response parameter - Thomas J. Vogl, Frankfurt a. Main / DE
08:00
6
Radiofrequency ablation (RFA) of hepatocellular carcinoma (HCC): CT texture analysis of the ablated area to predict local recurrence - Daniele Autelitano, Verona / IT
08:00
7
Immunonutritive scoring for patients with hepatocellular carcinoma undergoing transarterial chemoembolisation: evaluation of the CALLY index - Lukas Müller, Mainz / DE
08:00
8
Augmented reality-guided percutaneous thermal ablation of small hepatic tumours: first clinical experience in human patients worldwide - Luigi Solbiati, Rozzano (Milano) / IT
08:00
9
Comparison of combined chemoembolisation and microwave ablation with chemoembolisation alone in patients with hepatocellular carcinoma beyond the Milan criteria: a propensity scoring matching study - Yu-dong Xiao, Changsha / CN
08:00
10
Does lipiodol retention pattern influence the treatment efficacy of computed tomography guided thermal ablation for hepatocellular carcinoma: a propensity scoring matching study - Yu-dong Xiao, Changsha / CN
08:00
